1.Analysis of MYOC gene variants among sporadic patients with primary open-angle glaucoma.
Xiaohuan ZHANG ; Dingding ZHANG ; Lulin HUANG ; Fang HAO ; Ying LIN ; Bo GONG ; Zhenglin YANG
Chinese Journal of Medical Genetics 2019;36(7):662-665
OBJECTIVE:
To screen for MYOC gene variants among sporadic patients with primary open angle glaucoma (POAG).
METHODS:
For 398 patients with POAG, Sanger sequencing was applied to detect potential variants of the MYOC gene.
RESULTS:
Eight patients (2.0%) were found to harbor variations of the MYOC gene. These included five types of variants, among which c.667C>T (p.Pro223Ser) and c.1138G>T (p.Asp380Tyr) were novel. c.382C>T (p.Arg128Trp), c.1109C>T(p.Pro370Leu) and c.1130C>A (p.Thr377Lys) were previously associated with POAG. Alignment of amino acid sequences of MYOC proteins of various species revealed that the two novel variants have occurred at highly conserved positions. c.1138G>T was predicted to be possible pathogenic by Bioinformatic analysis.
CONCLUSION
Two novel variants of the MYOC gene were detected among sporadic POAG patients, which enriched its variant spectrum.
Cytoskeletal Proteins
;
genetics
;
Eye Proteins
;
genetics
;
Glaucoma, Open-Angle
;
genetics
;
Glycoproteins
;
genetics
;
Humans
;
Mutation
2.Clinical characteristics of four children with 3M syndrome and a literature review.
Ningan XU ; Kangxiang LIU ; Yan ZHONG
Chinese Journal of Medical Genetics 2023;40(7):795-801
OBJECTIVE:
To analyze the clinical features of 3M syndrome and effect of growth hormone therapy.
METHODS:
Clinical data of four children diagnosed with 3M syndrome by whole exome sequencing at Hunan Children's Hospital from January 2014 to February 2022 were retrospectively analyzed, which included clinical manifestation, results of genetic testing and recombinant human growth hormone (rhGH) therapy. A literature review was also carried our for Chinese patients with 3M syndrome.
RESULTS:
The clinical manifestations of the 4 patients included severe growth retardation, facial dysmorphism and skeletal malformations. Two patients were found to harbor homozygous variants of CUL7 gene, namely c.4717C>T (p.R1573*) and c.967_993delinsCAGCTGG (p.S323Qfs*33). Two patients were found to harbor 3 heterozygous variants of the OBSL1 gene including c.1118G>A (p.W373*), c.458dupG (p.L154Pfs*1002) and c.690dupC (p.E231Rfs*23), among which c.967_993delinsCAGCTGG and c.1118G>A were unreported previously. Eighteen Chinese patients with 3M syndrome were identified through the literature review, including 11 cases (11/18, 61.1%) carrying CUL7 gene variants and 7 cases (7/18, 38.9%) carrying OBSL1 gene variants. The main clinical manifestations were in keeping with previously reported. Four patients were treated with growth hormone, 3 showed obvious growth acceleration, and no adverse reaction was noted.
CONCLUSION
3M syndrome has a typical appearance and obvious short stature. To attain accurate diagnosis, genetic testing should be recommended for children with a stature of less than -3 SD and facial dysmorphism. The long-term efficacy of growth hormone therapy for patients with 3M syndrome remains to be observed.
Humans
;
Child
;
Retrospective Studies
;
Dwarfism/genetics*
;
Muscle Hypotonia/genetics*
;
Growth Hormone/therapeutic use*
;
Cytoskeletal Proteins/genetics*
5.Analysis of MYH3 gene variation and prenatal diagnosis for two pedigrees affected with congenital arthrogryposis.
Xueqin XU ; Lirong DING ; Huanzheng LI ; Zhaoke ZHENG ; Shaohua TANG
Chinese Journal of Medical Genetics 2019;36(5):447-450
OBJECTIVE:
To explore the genetic etiology of two pedigrees affected with congenital arthrogryposis.
METHODS:
Whole exome sequencing (WES) was used to screen potential variations in the proband. Suspected variations were analyzed with bioinformatics software and validated by Sanger sequencing.
RESULTS:
A heterozygous c.1123G>A (p.Glu375Lys) variation was detected in the proband and an affected fetus from pedigree 1, while a de novo heterozygous c.118 G>A (p.Val40Met) variation was detected in an affected fetus from pedigree 2.
CONCLUSION
The two heterozygous variations of the MYH3 gene probably underlie the disease in the pedigrees. Above results have facilitated genetic counseling and prenatal diagnosis.
Arthrogryposis
;
Cytoskeletal Proteins
;
genetics
;
Female
;
Heterozygote
;
Humans
;
Mutation
;
Pedigree
;
Pregnancy
;
Prenatal Diagnosis
;
Whole Exome Sequencing
6.Update of asthenospermia-related genes and proteins.
Qi-zhao ZHOU ; Chun-qiong FENG ; Xiang-ming MAO
National Journal of Andrology 2009;15(9):836-839
One of the most common causes of male infertility is asthenospermia, whose pathogenesis, however, is not yet clear. Recent researches have found that some genes (such as tektin-2, DNAI1, DNAH5, DNAH11, AKAP4, SEPT4 and Smcp) and proteins (such as sperm proteins ACTB, ANXA5, PRM1, PRM2 and SABP and seminal proteins Tf, PSA, PAP and Fractalkine) are associated with asthenospermia. The finding of these molecular markers has provided a base for the explanation of the molecular mechanism of asthenospermia, and these markers may become the diagnostic and therapeutic targets of the disease.
A Kinase Anchor Proteins
;
genetics
;
Animals
;
Asthenozoospermia
;
genetics
;
metabolism
;
Cytoskeletal Proteins
;
genetics
;
DNA Methylation
;
genetics
;
GTP Phosphohydrolases
;
genetics
;
Humans
;
Male
;
Mutation
;
Septins
7.Analysis of MYOC gene mutation in a Chinese glaucoma family with primary open-angle glaucoma and primary congenital glaucoma.
Ye-hong ZHUO ; Mei WANG ; Yan-tao WEI ; Ya-lin HUANG ; Jian GE
Chinese Medical Journal 2006;119(14):1210-1214
BACKGROUNDGlaucoma is one of the leading causes of blindness in the world. Primary open-angle glaucoma (POAG) and primary congenital glaucoma (PCG) are subtypes of glaucoma. Myocillin is the first gene identified to be involved in POAG. Recently, myocillin mutation has been found in PCG. In this context, we reported a special glaucoma pedigree, which was composed of both PCG and POAG patients, and analyzed the mutation of myocillin in this pedigree.
METHODSThe family was composed of the parents, a son and a daughter. All members of the family underwent the complete ophthalmologic examinations. All coding exons 1 - 3 and flanking introns of myocilin gene were screened for sequence alterations by polymerase chain reaction and direct DNA sequencing.
RESULTSThe son was the proband, who was diagnosed as PCG in both eyes. The father was diagnosed as POAG in the right eye, the left eye was still normal. Both the sister and the mother of the proband had normal intraocular pressure without glaucomatous optic disc changes. The mutations in intron 2 of myocilin gene were detected in the family. While the proband and the father were homozygous, the mother and the sister were heterozygous for the mutation.
CONCLUSIONSHomozygous mutation in intron 2 of myocilin gene is involved in both POAG and PCG. It is suggested that the pathogenesis might be overlapping in POAG and PCG.
Cytoskeletal Proteins ; genetics ; Eye Proteins ; genetics ; Female ; Glaucoma ; congenital ; genetics ; Glaucoma, Open-Angle ; genetics ; Glycoproteins ; genetics ; Humans ; Introns ; Male ; Mutation ; Pedigree
8.Diagnosis of a child with mitochondrial myopathy and cerebellar atrophy with ataxia due to compound heterozygous variants of MSTO1 gene.
Yang TIAN ; Zhen SHI ; Chi HOU ; Wenjuan LI ; Haixia ZHU ; Xiaojing LI ; Wenxiong CHEN
Chinese Journal of Medical Genetics 2022;39(4):417-420
OBJECTIVE:
To explore the genetic basis for a child with myopathy and cerebellar atrophy with ataxia.
METHODS:
Clinical examinations and laboratory testing were carried out for the patient. The proband and the parents' genomic DNA was extracted from peripheral blood samples and subjected to trio whole-exome sequencing. Candidate variant was validated by Sanger sequencing.
RESULTS:
The 1-year-and-8-month-old boy manifested motor developmental delay, ataxia, hypomyotonia, increased serum creatine kinase. Cranial MRI showed cerebellar atrophy with progressive aggravation. Genetic testing revealed that the patient has harbored compound heterozygous variants of the MSTO1 gene, namely c.13delG (p.Ala5ProfsTer68) and c.971C>T (p.Thr324Ile), which were respectively inherited from his mother and father. The former was unreported previously and was predicted to be likely pathogenic, whilst the latter has been reported previously and was predicted to be of uncertain significance.
CONCLUSION
The compound heterozygous c.13delG (p.Ala5ProfsTer68) and c.971C>T (p.Thr324Ile) variants probably underlay the disease in the proband. Above finding has enriched the spectrum of MSTO1 gene variants underlying mitochondrial myopathy and cerebellar atrophy with ataxia.
Ataxia/genetics*
;
Atrophy/genetics*
;
Cell Cycle Proteins/genetics*
;
Child
;
Cytoskeletal Proteins/genetics*
;
Humans
;
Infant
;
Male
;
Mitochondrial Myopathies
;
Mutation
;
Neurodegenerative Diseases
;
Whole Exome Sequencing
9.Gluconate 5-dehydrogenase (Ga5DH) participates in Streptococcus suis cell division.
Zhongyu SHI ; Chunling XUAN ; Huiming HAN ; Xia CHENG ; Jundong WANG ; Youjun FENG ; Swaminath SRINIVAS ; Guangwen LU ; George F GAO
Protein & Cell 2014;5(10):761-769
Bacterial cell division is strictly regulated in the formation of equal daughter cells. This process is governed by a series of spatial and temporal regulators, and several new factors of interest to the field have recently been identified. Here, we report the requirement of gluconate 5-dehydrogenase (Ga5DH) in cell division of the zoonotic pathogen Streptococcus suis. Ga5DH catalyzes the reversible reduction of 5-ketogluconate to D-gluconate and was localized to the site of cell division. The deletion of Ga5DH in S. suis resulted in a plump morphology with aberrant septa joining the progeny. A significant increase was also observed in cell length. These defects were determined to be the consequence of Ga5DH deprivation in S. suis causing FtsZ delocalization. In addition, the interaction of FtsZ with Ga5DH in vitro was confirmed by protein interaction assays. These results indicate that Ga5DH may function to prevent the formation of ectopic Z rings during S. suis cell division.
Bacterial Proteins
;
chemistry
;
genetics
;
metabolism
;
Cell Division
;
Cell Shape
;
Cytoskeletal Proteins
;
chemistry
;
genetics
;
metabolism
;
Mutation
;
Oxidoreductases
;
deficiency
;
genetics
;
metabolism
;
Protein Binding
;
Streptococcus suis
;
enzymology
10.Non-muscle myosin heavy chain 9 gene-related disorders with thrombocytopenia: report of two pedigrees and literature review.
Shu Ting MAO ; Bai LI ; Dao WANG ; Shan Shan LIU ; Shu Fang SU ; Lin Lin WEI ; Fang Yuan CHAI ; Ying LIU ; Yu Feng LIU
Chinese Journal of Pediatrics 2023;61(9):833-838
Objective: To summarize the clinical characteristics and gene variants of 2 pedigrees of non-muscle myosin heavy chain 9 related diseases (MYH9-RD) in children. Methods: The basic information, clinical features, gene variants and laboratory tests of MYH9-RD patients from 2 pedigrees confirmed in the First Affiliated Hospital of Zhengzhou University in November 2021 and July 2022 were analyzed retrospectively. "Non-muscle myosin heavy chain 9 related disease" "MYH9" and "children" were used as key words to search at Pubmed database, CNKI and Wanfang database up to February 2023. The MYH9-RD gene variant spectrum and clinical data were analyzed and summarized. Results: Proband 1 (male, 11 years old) sought medical attention due to epistaxis, the eldest sister and second sister of proband 1 only showed excessive menstrual bleeding, the skin and mucous membrane of the their mother were prone to ecchymosis after bumping, the uncle of proband 1 had kidney damage, and the maternal grandmother and maternal great-grandmother of proband 1 had a history of cataracts. There were 7 cases of phenotypic abnormalities in this pedigree. High-throughput sequencing showed that the proband 1 MYH9 gene had c.279C>G (p.N93K) missense variant, and family verification analysis showed that the variant was inherited from the mother. A total of 4 patients including proband 1 and family members were diagnosed with MYH9-RD. The proband 2 (female, 1 year old) sought medical attention duo to fever and cough, and the father's physical examination revealed thrombocytopenia. There were 2 cases of phenotypic abnormalities in this pedigree. High-throughput sequencing showed that there was a c.4270G>A (p.D1424N) missense variant in the proband 2 MYH9 gene, and family verification analysis showed that the variant was inherited from the father. A total of 2 patients including proband 2 and his father were diagnosed with MYH9-RD. A total of 99 articles were retrieved, including 32 domestic literatures and 67 foreign literatures. The MYH9-RD cases totaled 149 pedigrees and 197 sporadic patients, including 2 pedigrees in our study. There were 101 cases with complete clinical data, including 62 sporadic cases and 39 pedigrees. There were 56 males and 45 females, with an average age of 6.9 years old. The main clinical manifestations were thrombocytopenia, skin ecchymosis, and epistaxis. Most patients didn't receive special treatment after diagnosis. Six English literatures related to MYH9-RD caused by c.279C>G mutation in MYH9 gene were retrieved. Italy reported the highest number of cases (3 cases). Twelve literatures related to MYH9-RD caused by c.4270G>A mutation in MYH9 gene were retrieved. China reported the highest number of cases (9 cases). Conclusions: The clinical manifestations of patients in the MYH9-RD pedigrees varied greatly. MYH9 gene c.279C>G and c.4270G>A mutations are the cause of MYH9-RD.
Infant
;
Humans
;
Female
;
Male
;
Child
;
Myosin Heavy Chains/genetics*
;
Ecchymosis
;
Epistaxis
;
Pedigree
;
Retrospective Studies
;
Muscular Diseases
;
Thrombocytopenia
;
Cytoskeletal Proteins